Characterization and Quantification of Alcohol-related Polyneuropathy by Magnetic Resonance Neurography
Overview
Authors
Affiliations
Background: We characterized and quantified peripheral nerve damage in alcohol-dependent patients (ADP) by magnetic resonance neurography (MRN) in correlation with clinical and electrophysiologic findings.
Methods: Thirty-one adult patients with a history of excessive alcohol consumption and age-/sex-matched healthy controls were prospectively examined. After detailed neurologic and electrophysiologic testing, the patient group was subdivided into ADP with alcohol-related polyneuropathy (ALN) and without ALN (Non-ALN). 3T MRN with anatomical coverage from the proximal thigh down to the tibiotalar joint was performed using dual-echo 2-dimensional relaxometry sequences with spectral fat saturation. Detailed quantification of nerve injury by morphometric (cross-sectional area [CSA]) and microstructural MRN markers (proton spin density [ρ], apparent T2-relaxation-time [T2 ]) was conducted in all study participants.
Results: MRN detected nerve damage in ADP with and without ALN. A proximal-to-distal gradient was identified for nerve T2-weighted (T2w)-signal and T2 in ADP, indicating a proximal predominance of nerve lesions. While all MRN markers differentiated significantly between ADP and controls, microstructural markers were able to additionally differentiate between subgroups: tibial nerve ρ at thigh level was increased in ALN (p < 0.0001) and in Non-ALN (p = 0.0052) versus controls, and T2 was higher in ALN versus controls (p < 0.0001) and also in ALN versus Non-ALN (p = 0.0214). T2w-signal and CSA were only higher in ALN versus controls.
Conclusions: MRN detects and quantifies peripheral nerve damage in ADP in vivo even in the absence of clinically overt ALN. Microstructural markers (T2 , ρ) are most suitable for differentiating between ADP with and without manifest ALN, and may help to elucidate the underlying pathomechanism in ALN.
Magnetic resonance neurography in spinal cord injury: Imaging findings and clinical significance.
Jende J, Heutehaus L, Preisner F, Verez Sola C, Mooshage C, Heiland S Eur J Neurol. 2024; 31(4):e16198.
PMID: 38235932 PMC: 11235803. DOI: 10.1111/ene.16198.
Mooshage C, Tsilingiris D, Schimpfle L, Seebauer L, Eldesouky O, Aziz-Safaie T Diabetologia. 2023; 67(2):275-289.
PMID: 38019287 PMC: 10789832. DOI: 10.1007/s00125-023-06050-y.
Pietsch A, Viehover A, Diem R, Weiler M, Korporal-Kuhnke M, Wildemann B Clin Neuroradiol. 2022; 33(2):383-392.
PMID: 36264352 PMC: 10219896. DOI: 10.1007/s00062-022-01219-1.